Leading Business Model Transformation in Health. Physician, Executive, and Innovator in Digital Health.
"(...) Medicine Development and commercialization will be dominated by Data companies with Biotech and Pharma companies playing the role of a substrate supplier to algorithms" (Dr. Michael Zaiac) The writing is on the wall. If this happens, it will be a seismic shift affecting all aspects of healthcare. For many established players, this will pose a major threat to their business model. But within this threat, there is also opportunity. For patients, for Data companies - and for a few Pharma companies who get it right. Thanks Michael Zaiac for spelling it out and Bora Erdemli for posting! #futureofhealthcare #datadrivenmedicine #genAI
In one of the afternoon sessions at BioTechX Europe, Michael Zaiac talked about the role of #genAI in #medicalaffairs, where we are today and where we will be. And, he finished it with his future vision where the today’s pharma value chain from discovery to commercialization is dominated by “data companies” with biotech / pharma playing the role ofa substrate supplier.
